FdaApplication
ANDA 213071
Identifiers
- fda_app_no: ANDA213071
Properties
| Property | Value |
|---|---|
| applicant_name | NIVAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2022-10-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CALCIUM GLUCONATE | CALCIUM GLUCONATE | 10GM/100ML (100MG/ML) | SOLUTION;INTRAVENOUS |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE | 1GM/10ML (100MG/ML) | SOLUTION;INTRAVENOUS |
| CALCIUM GLUCONATE | CALCIUM GLUCONATE | 5GM/50ML (100MG/ML) | SOLUTION;INTRAVENOUS |
3 products